# Heartland Osteoporosis Prevention Study

> **NCT02186600** · PHASE3 · COMPLETED · sponsor: **University of Nebraska** · enrollment: 276 (actual)

## Conditions studied

- Osteopenia

## Interventions

- **DRUG:** Calcium Carbonate
- **DRUG:** Vitamin D3
- **DRUG:** Risedronate
- **BEHAVIORAL:** Bone-loading exercises

## Key facts

- **NCT ID:** NCT02186600
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02-01
- **Primary completion:** 2019-06-01
- **Final completion:** 2019-06-01
- **Target enrollment:** 276 (ACTUAL)
- **Last updated:** 2023-10-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02186600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02186600, "Heartland Osteoporosis Prevention Study". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT02186600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*